Thu 17 Aug 2023
AI and Drug Repurposing: Farewell, serendipity?
Our pledge to make therapies available for patients, faster, and why Artificial Intelligence is the key for small molecule repurposing
Thu 07 Dec 2023
Appointment of Dr Eckhard von Keutz as Scientific Advisor
Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor
Thu 05 Oct 2023
Kantify speaking at Slush'D Leuven
Kantify will be speaking in the panel on "AI: redefining business or enhancing roles"
Mon 22 May 2023
Pitch and Meet at the Tech.eu Summit
Kantify has been selecting to pitch at the Tech.eu Summit 2023 and will present Zeptomics, its solution for AI powered small molecule discovery
Fri 10 Mar 2023
Portrait in BECI Magazine, Brussels Business
In the March Edition of Brussels Business, a 2 page portrait is dedicated to our CEO and our team
Fri 03 Mar 2023
Upcoming talk: in silico drug discovery and animal testing
Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"
Mon 17 Oct 2022
Kantify & Mcule harness data to accelerate drug discovery
Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction
Wed 20 Jul 2022
Fragile X Syndrome: Innovative Approaches to Finding a Cure
Join the talk of our CTO at this cornerstone online event of the Fragile-X patient and research communityt
Mon 30 May 2022
Targeted Protein Degradation : Kantify at Proteocure event
Kantify spoke about the latest progress of AI/ML for Degraders at the event of Proteocure
Fri 19 Mar 2021
Kantify announces its new drug discovery technology
Kantify announces ZeptoNet, its new Virtual screening technology of small molecules
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.